Why did Metaplanet's Bitcoin holdings surge?
How is the Israel-Iran conflict impacting oil prices?
What caused Uber and unions to settle driver wage dispute?
Why is Trump launching a mobile phone company?
How did Trump's approval affect U.S. Steel's stock?
What explains AMD's recent stock rally?
Why are WhatsApp ads now rolling out?
Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal
benzinga.com/m-a/25/06/45949485/supernus-pharma-acquires-maker-of-postpartum-depression-drug-zurzuvae-in-795-million-deal
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Monday agreed to acquire Sage Therapeutics, Inc. (NASDAQ:SAGE) for $12.00 per share in cash, or an aggregate of up to approximately $795 million.
The deal consideration includes $8.50 per share in cash (or an aggregate of approximately $561…
This story appeared on benzinga.com, 2025-06-16 13:45:42.